Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001193125-26-264287

Options or other derivatives

  • Director acquired 13,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

High Katherine A · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-05 Grant or award : show line 1 in the form Stock Option (Right to Buy) +13,000 13,000 D
Loading xslF345X06/ownership.xml…